Wegovy® Online — See If You Qualify for Weight Management

The only semaglutide brand FDA-approved specifically for chronic weight management — evaluated and prescribed by a licensed provider, entirely online.
  • FDA-approved for chronic weight management
  • Once-weekly injectable pen
  • Also approved to reduce cardiovascular risk in certain adults with heart disease
Eligibility required. A licensed provider must evaluate your medical history before any prescription is written.
Start Your Free Visit

What Is Wegovy?

Wegovy is the brand name for semaglutide dosed specifically for weight management — it's the version of this GLP-1 medication that carries a dedicated FDA approval for chronic weight loss in adults with obesity, or who are overweight with a related health condition. That distinguishes it from Ozempic, which contains the same active ingredient but is approved only for type 2 diabetes.

Wegovy has also picked up two additional FDA approvals beyond weight management: reducing the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with established heart disease who are overweight or living with obesity, and treating a liver condition called MASH (metabolic dysfunction-associated steatohepatitis).

How Does Wegovy Work?

Semaglutide mimics GLP-1, a hormone your gut naturally produces after eating. It slows the rate food empties from your stomach and signals your brain to reduce hunger and cravings — the combination that drives sustained calorie reduction over time. Dosing starts low and increases gradually over roughly four to five months to help your body adjust, with most people reaching their steepest weight loss between months twelve and fifteen of consistent use.

Response varies by person — some people see rapid, earlier results, while others see more gradual change as they reach a maintenance dose. Your provider will track your progress and adjust your plan accordingly.

Am I a Candidate for Wegovy?

A licensed provider makes the final determination, but candidates typically:
  • Have a BMI of 30 or higher, or 27+ with a weight-related condition (like high blood pressure or high cholesterol)
  • Don't have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2)
  • Aren't pregnant or planning pregnancy
  • Have discussed any history of pancreatitis, gallbladder disease, or severe gastrointestinal conditions with their provider
If your primary concern is blood sugar management rather than weight loss, your provider may instead discuss Ozempic, which shares Wegovy's active ingredient but is approved specifically for type 2 diabetes.

How Zealthy's Process Works

1. Complete your health intake.

A short questionnaire covering your medical history, current medications, and weight-loss goals.

Meet your provider.

A licensed clinician reviews your information and discusses whether Wegovy — or an alternative like Zepbound — is the right fit.

3. Receive your prescription, if appropriate.

Sent directly to a pharmacy for pickup or delivery.

4. Stay on track.

Ongoing check-ins to manage side effects, adjust your dose, and monitor progress toward your goals.
Check My Eligibility

Cost and Insurance

Wegovy's list price runs well over a thousand dollars a month without insurance, though coverage varies widely by plan — some commercial insurers cover it for weight management, especially with prior authorization, while others don't cover GLP-1s for this indication at all. Novo Nordisk offers a savings card that can meaningfully lower out-of-pocket costs for eligible patients. Zealthy's clinical visit fee is billed separately from the medication, which your pharmacy charges according to your specific coverage.

Frequently Asked Questions

Is Wegovy the same as Ozempic?
How is Wegovy different from Zepbound?
How long does it take to see results?
What are the most common side effects?
How is Wegovy administered?

Important Safety Information

Wegovy is FDA-approved for chronic weight management in eligible adults, and for certain cardiovascular and liver-related indications. It carries a boxed warning for risk of thyroid C-cell tumors based on animal studies and should not be used by patients with a personal or family history of MTC or MEN 2. This page is informational and does not replace a one-on-one evaluation with a licensed healthcare provider.

Ready to see if Wegovy fits your goals?

Start Your Free Assessment